Pura Vida Investments’s NxStage Medical Inc. NXTM Stock Holding History

Pura Vida Investments’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,600	Closed	-$278K	–	101
2016 Q4	$278K	Sell	10,600 -86,500	-89%	-$2.14M	0.1%	63
2016 Q3	$2.43M	Buy	+97,100	New	+$2.26M	0.74%	56
2016 Q2	–	Sell	-50,000	Closed	-$750K	–	96
2016 Q1	$750K	Buy	+50,000	New	+$838K	0.34%	60
2015 Q3	–	Sell	-100,000	Closed	-$1.43M	–	77
2015 Q2	$1.43M	Buy	+100,000	New	+$1.69M	0.73%	51

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pura Vida Investments's NXTM Position: Q3 2017 in Review

Pura Vida Investments sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 221,685 shares — an estimated $5.56M sold.

Pura Vida Investments first reported a position in NXTM in Q4 2014 and held it in 11 quarters. The position peaked at $9.12M in Q3 2016. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

Pura Vida Investments reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
Pura Vida Investments sold 221,685 NxStage Medical Inc. shares in Q3 2017, an estimated $5.56M.
Pura Vida Investments first reported a position in NxStage Medical Inc. in Q4 2014 and held it in 11 quarters.
Pura Vida Investments's NxStage Medical Inc. position peaked at $9.12M in Q3 2016.
168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Pura Vida Investments's 13F filing for Q3 2017, filed 14 Nov 2017.